Coloplast A/S

OTC: CLPBY · Real-Time Price · USD
9.60
0.07 (0.72%)
At close: Jun 06, 2025, 3:58 PM

Coloplast A/S Income Statement

Financials in DKK. Fiscal year is October - September.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Revenue
27.79B 27.45B 27.03B 26.3B 25.53B 25B 24.5B 24.33B 24.07B 23.52B 22.58B 21.62B 20.61B 19.86B 19.43B 18.92B 18.5B 18.57B
Cost of Revenue
9.03B 8.94B 8.76B 8.54B 8.39B 8.31B 8.17B 7.97B 7.68B 7.37B 7.05B 6.74B 6.44B 6.22B 6.11B 5.96B 5.91B 5.96B
Gross Profit
18.77B 18.52B 18.27B 17.76B 17.14B 16.69B 16.33B 16.37B 16.39B 16.14B 15.53B 14.88B 14.17B 13.64B 13.31B 12.95B 12.59B 12.61B
Operating Income
7.57B 7.47B 7.38B 7.12B 6.97B 6.83B 6.77B 6.9B 6.93B 6.58B 6.44B 6.51B 6.36B 6.43B 6.36B 5.98B 5.75B 5.92B
Interest Income
114M 150M 120M 121M 124M 130M 109M 85M 127M 135M 136M 134M 99M 147M 147M 147M 104M 11M
Pretax Income
6.49B 6.61B 6.39B 6.32B 6.3B 6.15B 6.03B 6.11B 6.17B 6B 6.13B 6.16B 6.11B 6.29B 6.23B 5.96B 5.63B 5.54B
Net Income
4.54B 4.88B 5.05B 4.97B 4.96B 4.87B 4.78B 4.78B 4.8B 4.63B 4.71B 4.78B 4.75B 4.9B 4.83B 4.56B 4.3B 4.24B
Selling & General & Admin
10.38B 10.23B 10.07B 9.68B 9.25B 8.94B 8.63B 8.6B 8.55B 8.28B 7.8B 7.32B 6.82B 6.44B 6.25B 6.1B 5.94B 5.99B
Research & Development
917M 899M 913M 925M 901M 889M 872M 858M 864M 877M 866M 856M 819M 774M 755M 723M 720M 725M
Other Expenses
-73M -56M -56M -13M -42M -43M -44M -33M -45M -44M -49M -43M -52M -44M -44M -44M -23M -25M
Operating Expenses
11.2B 11.05B 10.89B 10.58B 10.12B 9.79B 9.48B 9.42B 9.37B 9.11B 8.62B 8.13B 7.59B 7.17B 6.96B 6.78B 6.63B 6.69B
Interest Expense
976M 861M 831M 799M 703M 734M 682M 587M 595M 431M 315M 229M 97M 29M 30M 35M 91M 253M
Selling & Marketing Expenses
9.2B 9.02B 8.82B 8.44B 8.05B 7.78B 7.52B 7.49B 7.43B 7.17B 6.8B 6.38B 5.96B 5.67B 5.49B 5.36B 5.18B 5.21B
Cost & Expenses
20.23B 19.99B 19.66B 19.13B 18.52B 18.11B 17.66B 17.39B 17.05B 16.48B 15.67B 14.87B 14.03B 13.39B 13.07B 12.74B 12.55B 12.65B
Income Tax Expense
1.95B 1.73B 1.34B 1.35B 1.33B 1.28B 1.24B 1.33B 1.37B 1.37B 1.42B 1.38B 1.36B 1.4B 1.41B 1.4B 1.33B 1.3B
Shares Outstanding (Basic)
2.25B 2.25B 2.25B 2.25B 2.25B 2.19B 2.18B 2.12B 2.12B 2.12B 2.12B 2.12B 2.13B 2.13B 2.13B 2.13B 2.13B 2.13B
Shares Outstanding (Diluted)
2.25B 2.25B 2.25B 2.25B 2.25B 2.19B 2.25B 2.13B 2.12B 2.12B 2.13B 2.13B 2.13B 2.13B 2.13B 2.13B 2.13B 2.13B
EPS (Basic)
2.03 2.17 2.26 2.24 2.27 2.26 2.24 2.25 2.26 2.18 2.22 2.25 2.23 2.30 2.27 2.14 2.02 1.99
EPS (Diluted)
2.03 2.17 2.26 2.23 2.26 2.24 2.22 2.25 2.26 2.17 2.21 2.25 2.23 2.30 2.26 2.14 2.02 1.99
EBITDA
8.78B 8.76B 8.59B 8.47B 8.22B 8.03B 7.94B 7.93B 8B 7.99B 7.77B 7.61B 7.39B 7.24B 7.16B 7B 6.78B 6.77B
EBIT
7.44B 7.45B 7.2B 7.12B 7B 6.89B 6.71B 6.7B 6.77B 6.43B 6.44B 6.39B 6.2B 6.43B 6.37B 6.19B 5.92B 5.89B
Depreciation & Amortization
1.33B 1.31B 1.29B 1.23B 1.17B 1.12B 1.07B 1.05B 1.05B 1.02B 930M 862M 811M 765M 792M 816M 821M 845M